ATA-100 (Formerly GNT0006) Gene Therapy Trial in Patients With LGMDR9
Clinical trial NCT05224505 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05224505
- Sponsor
- Atamyo Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2025-02-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.